Print Page

Products found to contain undeclared medicines

 
The United States: Sit and Slim II: Public Notification - Hidden Drug Ingredients Sibutramine and Phenolphthalein
 
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Sit and Slim II.

FDA laboratory analysis confirmed that Sit and Slim II contains sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. These products may also interact, in life-threatening ways, with other medications a consumer may be taking. Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it presents a cancer-causing risk.

Please refer to the following website in FDA for details: http://www.fda.gov/Safety/MedWatch/../ucm418500.htm

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Saturday, October 11, 2014
Issued at HKT 14:15
 
Related Information:
Canada: Foreign Product Alert: Star Majestic Slimming, Sit and Slim II, Ginseng ... Posted 2015-01-31
The United States: Public Notification: Mayhem Contains Hidden Drug Ingredients ... Posted 2014-11-14
Singapore: HSA Alerts Public to Two Illegal Products Containing Potent Undeclare... Posted 2014-11-08
The United States: FDA warns consumers not to use “Ginseng Kianpi Pil” due to po... Posted 2014-10-31
Australia: Safety Advisory: Star Majestic Slimming capsules were found to contai... Posted 2014-04-01
 
back